Histiocytic Sarcoma in a 3-Year-Old Male: a Case Report

Total Page:16

File Type:pdf, Size:1020Kb

Histiocytic Sarcoma in a 3-Year-Old Male: a Case Report Histiocytic Sarcoma in a 3-Year-Old Male: A Case Report Samuel Buonocore, MD*; Alfredo L. Valente, MD‡; Daniel Nightingale, MD‡; Jeffrey Bogart, MD§; and Abdul-Kader Souid, MD, PhD* ABSTRACT. We describe a pediatric patient with his- CASE REPORT tiocytic sarcoma involving the T6 and L4 vertebral bodies This previously healthy 3-year-old boy experienced intermit- and the lungs. His tumor progressed during chemother- tent low back pain radiating to the right inguinal region for ϳ2 apy designed for Langerhans’ cell histiocytosis and sar- months. His symptoms initially responded to ibuprofen. The pain coma. High-dose radiation, on the other hand, was intensity increased over a 2-week period, and he refused to walk. effective. Pediatrics 2005;116:e322–e325. URL: www. Review of systems was significant for pain with urination. With the exception of being unable to stand, his physical examination pediatrics.org/cgi/doi/10.1542/peds.2005-0026; sarcoma, was unremarkable. The laboratory tests showed normal blood histiocytes, Langerhans’ cell histiocytosis, histiocytic sar- counts and normal liver and renal function. An MRI showed coma. collapse of the T6 and L4 vertebral bodies and a soft tissue mass in the anterior epidural space at the level of L4 (Fig 1 A and B). The chest and abdominal computed tomography (CT) scans were nor- ABBREVIATIONS. LCH, Langerhans’ cell histiocytosis; CT, com- mal. Bone marrow aspiration revealed no malignant infiltration. A puted tomography; 2CdA, 2-chlorodeoxyadenosine. technetium bone scan showed increased uptake limited to the T6 and L4 regions. CT-scan–guided needle biopsy of the L4 mass revealed infiltrative proliferation of the bone and soft tissue by istiocytic and dendritic neoplasms are rare, sheets and clusters of large ovoid cells with abundant eosinophilic cytoplasm (Fig 2A). The nuclei were round/oval, eccentric, and especially in children. These tumors arise pleomorphic with occasional grooving. Distinct, small nucleoli Hfrom antigen-processing phagocytes (histio- were present. Multinucleated giant cells were also present (Fig cytes) and antigen-presenting dendritic cells. The cell 2B). Immunohistochemistry showed expression of CD68 (macro- types are derived from hematopoietic or mesenchy- phage/histiocytic marker; Fig 2C) and focal expression of S100 1 protein and CD15 (granulocyte marker). The following markers mal stem cells. Currently, the World Health Orga- were negative: CD1a (Langerhans’ and immature T-cell marker; nization includes the following 6 entities under this Fig 2D), CD3 (T-cell marker), CD20/CD79a (B-cell markers), CD23 designation: Langerhans’ cell histiocytosis (LCH), (B-cell chronic lymphocytic leukemia/lymphoproliferative dis- ease marker), CD21 (mature B-cell and follicular dendritic cell Langerhans’ cell sarcoma, follicular dendritic cell marker), CD35 (follicular dendritic cell marker), CD30 (anaplastic sarcoma, interdigitating dendritic cell sarcoma, den- large-cell lymphoma and Reed-Sternberg cell marker), ALK (ana- dritic cell sarcoma not otherwise specified, and his- plastic large-cell lymphoma marker), desmin, smooth muscle ac- tiocytic sarcoma.2 The latter malignancy is a prolif- tin, and myeloperoxidase (myeloid cell marker). Electron micros- copy revealed numerous cytoplasmic lysosomes; however, eration of histiocytes (tissue macrophages), which Birbeck granules (typical of Langerhans’ cells), interdigitating cell are characterized by positive expression of the mac- junctions, cytoplasmic projections, and desmosomes were not rophage-associated antigen CD68, negative expres- identified. These morphologic and immunohistochemical features sion of the T-cell–associated antigen CD1a, negative are typical of histiocytic sarcoma (Table 1). The patient was started on LCH-based therapy (prednisone, expression of the dendritic cell–associated antigens 6-merpactopurine, methotrexate, vinblastine, and etoposide). CD21/CD35, and lack of Birbeck granules on elec- However, within ϳ2 weeks, his condition deteriorated and he tron microscopy.3 developed neurogenic bladder. He then received radiation (4500 cGy in 180-cGy fractions) to the L4 vertebral body and associated The rarity of histiocytic sarcoma continues to make paraspinal mass. He gradually improved. At the end of the radi- its management challenging, and we are unaware of ation treatment, he was walking without limitation and had full any recommended therapy for young children. We bladder control. A follow-up MRI showed significant diminution describe a child with histiocytic sarcoma to highlight of the paraspinal mass (Fig 1 C and D); the T6 vertebra remained unchanged. his poor response to LCH- and sarcoma-based che- The radiation was followed by 3 monthly cycles of cyclophos- motherapy. By contrast, high-dose radiation proved phamide (2.2 g/m2) and actinomycin D (0.045 mg/kg). At the end to be effective. of the third cycle, his chest CT scan revealed 2 nodules in the right and left upper lobes. A positron emission tomography scan showed abnormal uptake limited to the lung nodules. The meta- static lesions were confirmed by a CT-guided biopsy. He received 2 From the Departments of *Pediatrics, ‡Pathology, and §Radiation Oncol- 2 monthly cycles of idarubicin (10 mg/m ) and 2-chlorodeoxya- 2 ogy, State University of New York, Upstate Medical University, Syracuse, denosine (2CdA [or cladribine] at 8 mg/m ). A follow-up chest CT New York. showed diminution of the lung lesions. Localized radiation (4500 Accepted for publication Feb 28, 2005. cGy at 180 cGy per fraction) was delivered to the metastatic lung doi:10.1542/peds.2005-0026 nodules. This treatment was followed by 6 monthly cycles of 2 No conflict of interest declared. 2CdA (8 mg/m ). Address correspondence to Abdul-Kader Souid, MD, PhD, Department of Pediatrics, State University of New York, Upstate Medical University, 750 E DISCUSSION Adams St, Syracuse, NY 13210. E-mail: [email protected] PEDIATRICS (ISSN 0031 4005). Copyright © 2005 by the American Acad- Histiocytes (tissue macrophages) are derived from emy of Pediatrics. hematopoietic monoblasts. These phagocytes contain e322 PEDIATRICS Vol.Downloaded 116 No. 2 from August www.aappublications.org/news 2005 www.pediatrics.org/cgi/doi/10.1542/peds.2005-0026 by guest on September 27, 2021 Fig 1. MRIs showing collapse of the T6 and L4 vertebral bodies (white arrows) (A) and associated soft tissue mass in the anterior epidural space at the L4 level (black double arrows) with cord compression (single black arrow) (A and B) and follow-up MRI (ϳ2 months postradiation to the L4 region) show- ing diminution of the soft tissue mass (C) and absence of cord compression (D). organelles (vacuoles and lysosomes) and enzymes diffuse/anaplastic large B-cell lymphoma, peripheral (lysozyme, ␣-1-antitrypsin, acid phosphatase, and T-cell lymphoma associated with hemophagocytic nonspecific esterases) capable of processing antigens syndrome, or lymphoma with associated reactive for T lymphocytes. The cells also lack Birbeck gran- macrophages (eg, histiocyte recruitments by mac- ules (typical of Langerhans’ cells), complex cell junc- rophage-activating factors).4,5 tions (typical of interdigitating dendritic cells), and Morphologically, tumor cells are characterized by desmosomes (typical of follicular dendritic cells). abundant eosinophilic cytoplasm (Fig 2A). The nu- CD68 (a lysosome-associated protein) is the most clei are eccentric and round/oval, with atypia vary- important antigen that detects macrophages.2 ing from mild to pleomorphic. The nucleoli are small Histiocytic sarcoma is an exceedingly rare ma- and distinct. Binucleated giant cells are common (Fig lignancy that demonstrates morphologic and immu- 2B). The ultrastructural features show numerous nophenotypic features of macrophage/histiocytic vacuoles and lysosomes. Interdigitating cell junc- differentiation. Before the development of immuno- tions and Birbeck granules are essentially absent. The histochemistry, this diagnosis was more common. It latter features distinguish this entity from Langer- is now recognized that most cases of “histiocytic hans’ and dendritic cell tumors, especially when sarcoma” described in the past actually represented S100 protein is positive (Table 1). The immunohisto- Downloaded from www.aappublications.org/newswww.pediatrics.org/cgi/doi/10.1542/peds.2005-0026 by guest on September 27, 2021 e323 Fig 2. A, Neoplastic cells showing abundant eosinophilic cytoplasm, round to oval vesicular nuclei, and dis- tinct nucleoli. B, Binucleated cells ad- mixed with stromal inflammatory in- filtrates. C, Strongly positive granular cytoplasmic staining for the lysosomal marker CD68 with the monoclonal an- tibody KP1. D, Negative CD1a stain. TABLE 1. Antigen-Detectable Profiles of Macrophage/Histiocytic and Dendritic Neoplasms CD1a CD21/CD35 CD68 Lysozyme S100 LCH/sarcoma ϩϪϩϮ* ϩ Interdigitating dendritic cell tumor/sarcoma ϪϪϮ* Ϯ* ϩ Follicular dendritic cell tumor/sarcoma ϪϩϮ* ϪϪ Dendritic cell sarcoma, not otherwise specified ϮϮϮϮϮ Histiocytic sarcoma ϪϪϩϩϮ* Case patient ϪϪϩϩϩ† * Expressed in ϳ25% to 50% of cases. † Focally positive.1 chemical profile shows expression of the lysosome- shared the rearrangements involving immunoglobu- associated (macrophage/histiocytic) markers CD68 lin heavy chain and T-cell receptor ␥-chain genes, (in 100% of cases) and lysozyme (in 94% of cases).1 suggesting lineage infidelity for the recurrent dis- The Langerhans’ cell, follicular dendritic cell, my- ease.7 Two other similar cases have also been de- eloid,
Recommended publications
  • Diagnostic Immunohistochemistry for Canine Cutaneous Round Cell Tumours — Retrospective Analysis of 60 Cases
    FOLIA HISTOCHEMICA ORIGINAL PAPER ET CYTOBIOLOGICA Vol. 57, No. 3, 2019 pp. 146–154 Diagnostic immunohistochemistry for canine cutaneous round cell tumours — retrospective analysis of 60 cases Katarzyna Pazdzior-Czapula, Mateusz Mikiewicz, Michal Gesek, Cezary Zwolinski, Iwona Otrocka-Domagala Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland Abstract Introduction. Canine cutaneous round cell tumours (CCRCTs) include various benign and malignant neoplastic processes. Due to their similar morphology, the diagnosis of CCRCTs based on histopathological examination alone can be challenging, often necessitating ancillary immunohistochemical (IHC) analysis. This study presents a retrospective analysis of CCRCTs. Materials and methods. This study includes 60 cases of CCRCTs, including 55 solitary and 5 multiple tumours, evaluated immunohistochemically using a basic antibody panel (MHCII, CD18, Iba1, CD3, CD79a, CD20 and mast cell tryptase) and, when appropriate, extended antibody panel (vimentin, desmin, a-SMA, S-100, melan-A and pan-keratin). Additionally, histochemical stainings (May-Grünwald-Giemsa and methyl green pyronine) were performed. Results. IHC analysis using a basic antibody panel revealed 27 cases of histiocytoma, one case of histiocytic sarcoma, 18 cases of cutaneous lymphoma of either T-cell (CD3+) or B-cell (CD79a+) origin, 5 cases of plas- macytoma, and 4 cases of mast cell tumours. The extended antibody panel revealed 2 cases of alveolar rhabdo- myosarcoma, 2 cases of amelanotic melanoma, and one case of glomus tumour. Conclusions. Both canine cutaneous histiocytoma and cutaneous lymphoma should be considered at the beginning of differential diagnosis for CCRCTs. While most poorly differentiated CCRCTs can be diagnosed immunohis- tochemically using 1–4 basic antibodies, some require a broad antibody panel, including mesenchymal, epithelial, myogenic, and melanocytic markers.
    [Show full text]
  • FT117 Langerhans Cell Histiocytosis with Histopathological Features
    FT117 Langerhans cell histiocytosis with histopathological features, single center experience Histopatolojik özellikleriyle langerhans hücreli histiyositoz, tek merkez deneyimi Fahriye KILINÇ Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Tıbbi Patoloji Anabilim Dalı, Konya Aim: Langerhans cell histiocytosis (LCH) is a rare histiocytic disease, occurring in 2-10 children per million and 1-2 adults per million, and may have a wide variety of clinical manifestations. Infiltration can develop in almost any organ (the most commonly reported organs are bone, skin, lymph nodes, lungs, thymus, liver, spleen, bone marrow and central nervous system). We aimed to evaluate the histopathological features of the lesions and review the literature in pediatric patients referred to our department for pathological examination and diagnosed as LCH. Materials and Methods: Retrospectively, childhood cases diagnosed with LCH in 2012-2019 were screened by hospital automation system. Age, gender, lesion localizations of the cases were recorded and histopathological features were reviewed. Results: 5 male and 5 female total of 10 cases were detected. The youngest 3 were under the age of 1, the oldest was 16 years old. Localization; 6 of the cases were bone (2 femur, 3 skull bone, 1 scapula), 2 skin, 1 bone and lymph node, 1 lung and lymph node. Histopathology revealed histiocytic cells with grooved nuclei, eosinophilic cytoplasm with eosinophils, and neutrophils in some cases. Immunohistochemical CD1a staining was positive in all cases and positivities were present with S100 in applied 9 cases, CD68 in 4. Ki67 proliferation index was studied in 2 patients with bone localization, 15% and 20%. Conclusion: The term LCH is due to the morphological and immunophenotypic similarity of the infiltrating cells of this disease to Langerhans cells specialized as dendritic cells in the skin and mucous membranes.
    [Show full text]
  • Skin Biopsy Diagnosis of Langerhans Cell Neoplasms
    Chapter 3 Skin Biopsy Diagnosis of Langerhans Cell Neoplasms Olga L. Bohn, Julie Teruya-Feldstein and Sergio Sanchez-Sosa Additional information is available at the end of the chapter http://dx.doi.org/10.5772/55893 1. Introduction This chapter reviews the clinical presentation, histopathology, immunoprofile and molecular features of Langerhans cell neoplasms of the skin including Langerhans cell histiocytosis (LCH) and its malignant counterpart, Langerhans cell sarcoma (LCS). Biopsy of the skin is a useful method to confirm LCH/LCS diagnosis, as cutaneous involvement is seen in more than 50% cases. Skin can be the only presenting site of LCH, but it is usually seen as an integral part of multisystemic disease involvement. Langerhans cells (LC) are bone marrow-derived antigen presenting cells [1]. Although LC, dendritic cells and monocytic/histiocytic cells share a common multipotential progenitor cells that reside in the bone marrow, to the date, myeloid derived macrophages and dendritic cells constitute divergent lines of differentiation from bone marrow precursors [2]. However, recent evidence demonstrates that LC can be generated from lymphoid-committed CD4low precur‐ sors, suggesting the role of lineage plasticity/ trans-differentiation and clonal infidelity [3-4]. LC can be found in the epidermis and mucosal lining of multiple organs including cervix, vagina, stomach and esophagus. The specific immunophenotypic profile is helpful distin‐ guishing LCs, as they can express CD1a and langerin (CD207); in addition the detection of Birbeck granules, seen in both pathological and resting LC is a prominent feature [5]. LCH encompasses a spectrum of disease characterized by an uncontrolled proliferation of LC [5].
    [Show full text]
  • THE AMERICAN JOURNAL of CANCER a Continuation of the Journal of Cancer Research
    THE AMERICAN JOURNAL OF CANCER A Continuation of The Journal of Cancer Research ~ VOLUMEXXXIV DECEMBER,1938 NUMBER4 SYNOVIAL SARCOMAS IN SEROUS BURSAE AND TENDON SHEATHS PROF. LOUIS BERGER, M.D. (From the Pathological Department, HBpital de I'Enfant-Jdsus, and the Anti-Cancer Center of Lava1 University, Quebec) Progress in the knowledge of malignant tumors arising from synovial tissue has been slow. In spite of some recent and valuable contributions, this chapter is far from complete. The reasons for this are threefold: first, the want of knowledge concerning the normal features and nature of synovial tissue, which was long studied in articulations only, although it is common, also, to serous bursae and tendon sheaths; second, the relative-perhaps only apparent-rarity of cases; finally, the lack of precision and even vagueness of the reports in the literature., Most of the older authors, and even some contemporary ones, interested primarily in the clinical or surgical aspects of the question, have been satisfied with a purely topographical diagnosis and have either neglected the histologic aspects of their tumors or described them only briefly and superficially. We have had the opportunity of studying five cases of synovial sarcoma, differing more or less from one another but all originating outside of articu- lations, that is in serous bursae or tendon sheaths, where these tumors are less known, but perhaps easier to study than in the more intricate tissues of the joints. THENORMAL SYNOVIAL TISSUE The prototype of synovial tissue is encountered in the synovial membranes of the joints, but all histologists admit that the lining tissue of the serous bursae and tendon sheaths is homologous with articular synovialis.
    [Show full text]
  • Histiocytic and Dendritic Cell Lesions
    1/18/2019 Histiocytic and Dendritic Cell Lesions L. Jeffrey Medeiros, MD MD Anderson Cancer Center Outline 2016 classification of Histiocyte Society Langerhans cell histiocytosis / sarcoma Erdheim-Chester disease Juvenile xanthogranuloma Malignant histiocytosis Histiocytic sarcoma Interdigitating dendritic cell sarcoma Follicular dendritic cell sarcoma Rosai-Dorfman disease Hemophagocytic lymphohistiocytosis Writing Group of the Histiocyte Society 1 1/18/2019 Major Groups of Histiocytic Lesions Group Name L Langerhans-related C Cutaneous and mucocutaneous M Malignant histiocytosis R Rosai-Dorfman disease H Hemophagocytic lymphohistiocytosis Blood 127: 2672, 2016 L Group Langerhans cell histiocytosis Indeterminate cell tumor Erdheim-Chester disease S100 Normal Langerhans cells Langerhans Cell Histiocytosis “Old” Terminology Eosinophilic granuloma Single lesion of bone, LN, or skin Hand-Schuller-Christian disease Lytic lesions of skull, exopthalmos, and diabetes insipidus Sidney Farber Letterer-Siwe disease 1903-1973 Widespread visceral disease involving liver, spleen, bone marrow, and other sites Histiocytosis X Umbrella term proposed by Sidney Farber and then Lichtenstein in 1953 Louis Lichtenstein 1906-1977 2 1/18/2019 Langerhans Cell Histiocytosis Incidence and Disease Distribution Incidence Children: 5-9 x 106 Adults: 1 x 106 Sites of Disease Poor Prognosis Bones 80% Skin 30% Liver Pituitary gland 25% Spleen Liver 15% Bone marrow Spleen 15% Bone Marrow 15% High-risk organs Lymph nodes 10% CNS <5% Blood 127: 2672, 2016 N Engl J Med
    [Show full text]
  • Cutaneous Neonatal Langerhans Cell Histiocytosis
    F1000Research 2019, 8:13 Last updated: 18 SEP 2019 SYSTEMATIC REVIEW Cutaneous neonatal Langerhans cell histiocytosis: a systematic review of case reports [version 1; peer review: 1 approved with reservations, 1 not approved] Victoria Venning 1, Evelyn Yhao2,3, Elizabeth Huynh2,3, John W. Frew 2,4 1Prince of Wales Hospital, Randwick, Sydney, NSW, 2033, Australia 2University of New South Wales, Sydney, NSW, 2033, Australia 3Sydney Children's Hospital, Randwick, NSW, 2033, Australia 4Department of Dermatology, Liverpool Hospital, Sydney, Sydney, NSW, 2170, Australia First published: 03 Jan 2019, 8:13 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.17664.1) Latest published: 03 Jan 2019, 8:13 ( https://doi.org/10.12688/f1000research.17664.1) Reviewer Status Abstract Invited Reviewers Background: Cutaneous langerhans cell histiocytosis (LCH) is a rare 1 2 disorder characterized by proliferation of cells with phenotypical characteristics of Langerhans cells. Although some cases spontaneously version 1 resolve, no consistent variables have been identified that predict which published report report cases will manifest with systemic disease later in childhood. 03 Jan 2019 Methods: A systematic review (Pubmed, Embase, Cochrane database and all published abstracts from 1946-2018) was undertaken to collate all reported cases of cutaneous LCH in the international literature. This study 1 Jolie Krooks , Florida Atlantic University, was registered with PROSPERO (CRD42016051952). Descriptive statistics Boca Raton, USA and correlation analyses were undertaken. Bias was analyzed according to Milen Minkov , Teaching Hospital of the GRADE criteria. Medical University of Vienna, Vienna, Austria Results: A total of 83 articles encompassing 128 cases of cutaneous LCH were identified.
    [Show full text]
  • Beyond Langerhans Cell Histiocytosis Related to Smoking
    Radiología. 2019;61(3):215---224 www.elsevier.es/rx RADIOLOGY THROUGH IMAGES Pulmonary histiocytosis: Beyond Langerhans cell ଝ histiocytosis related to smoking a b a c d b,e,∗ C. Trejo Gallego , J. Bueno , E. Cruces , E.B. Stelow , N. Mancheno˜ , L. Flors a Servicio de Radiología, Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain b Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, VA, United States c Department of Pathology, University of Virginia Health System, Charlottesville, VA, United States d Servicio de Anatomía Patológica, Hospital Universitario y Politécnico la Fe, Valencia, Spain e Department of Radiology, One Hospital Dr, University of Missouri Health System, Columbia, MO, United States Received 21 October 2017; accepted 16 November 2018 Available online 24 January 2019 KEYWORDS Abstract Langerhans cells Objective: To review the imaging findings for the different types of pulmonary histiocy- histiocytosis; tosis. In particular, in addition to the well-known pulmonary Langerhans cell histiocytosis Erdheim---Chester related to smoking and its possible appearance in nonsmokers, we focus on non-Langerhans disease; cell histiocytosis in Rosai---Dorfman disease and Erdheim---Chester disease. We also review the Sinus histiocytosis; etiopathogenesis, histology, clinical presentation, and treatment of pulmonary histiocytosis. Computed Conclusion: Langerhans cell histiocytosis, Rosai---Dorfman disease, and Erdheim---Chester dis- tomography ease are idiopathic
    [Show full text]
  • Langerhans Cell Sarcoma with an Aberrant Cytoplasmic CD3 Expression Zhaodong Xu1*, Ruth Padmore1, Carolyn Faught2, Lisa Duffet2 and Bruce F Burns3
    Xu et al. Diagnostic Pathology 2012, 7:128 http://www.diagnosticpathology.org/content/7/1/128 CASE REPORT Open Access Langerhans cell sarcoma with an aberrant cytoplasmic CD3 expression Zhaodong Xu1*, Ruth Padmore1, Carolyn Faught2, Lisa Duffet2 and Bruce F Burns3 Abstract: Langerhans cell sarcoma is a rare and aggressive high grade hematopoietic neoplasm with a dismal prognosis. It has a unique morphological and immunotypic profile with a CD1a/ langerin/S100 + phenotype. T cell lineage markers except for CD4 in Langerhans cell sarcoma have not been documented previously. We report a case of 86 year-old male of Caucasian descent who presented with an enlarging right neck mass over 2 months with an underlying unknown cause of anemia. Computed tomography scan of the neck, chest and abdomen revealed generalized lymphadenopathy and mild splenomegaly suspicious for lymphoma. Diagnostic core biopsy performed on right neck mass revealed a possible T cell lymphoma with expression of T cell lineage specific marker CD3 but conclusive diagnosis could not be made due to insufficient core biopsy sample. Further excisional biopsy performed on a left inguinal node showed a hematopoietic neoplasm with features of Langerhans cell sarcoma with a focal cytoplasmic CD3 expression in 30-40% of the tumor cells. PCR for T cell receptor (TCR) gene rearrangement failed to demonstrate a clonal gene rearrangement in the tumor cells arguing against a T cell lineage transdifferentiation, suggesting an aberrant CD3 expression. To the best of our knowledge, this case represents the first report of Langerhans cell sarcoma with an aberrant cytoplasmic CD3 expression. Virtual slides: http://www.diagnosticpathology.diagnomx.eu/vs/2065486371761991 Keywords: Langerhans cell sarcoma (LCS), Langerhans cell histiocytosis (LCH), CD3, Aberrant expression, Lineage plasticity, Transdifferentiation Background langerin/S100+ [2,3] but without B- and T-cell lineage According to the most recent WHO Classification of markers except for CD4 [4].
    [Show full text]
  • Case of Pleomorphic Dermal Sarcoma of the Eyelid Treated with Micrographic Surgery and Secondary Intention Healing
    JI Kim, et al pISSN 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 28, No. 5, 2016 http://dx.doi.org/10.5021/ad.2016.28.5.632 CASE REPORT Case of Pleomorphic Dermal Sarcoma of the Eyelid Treated with Micrographic Surgery and Secondary Intention Healing Jung-In Kim, Young-Jun Choi, Hyun-Min Seo2, Han-Saem Kim, Jae Yun Lim, Dong-Hoon Kim1, Seoung Wan Chae1, Ga-Young Lee, Won-Serk Kim Departments of Dermatology and 1Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 2Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Pleomorphic dermal sarcoma (PDS) is a rare mesenchymal dence of recurrence or periocular functional defects during neoplasm sharing histopathological features with atypical fi- a 2-year follow-up without adjuvant therapy. Although the broxanthoma (AFX), but has additional features of deep in- PDS is highly malignant, complete excision under micro- vasion of the superficial subcutis, tumor necrosis and vas- graphic surgery can prevent recurrence without adjuvant cular/perineural invasion. It is not well documented in the lit- therapy. Also, the secondary intention healing is an effective erature because of its rarity, and its clinical course has been method for closure of large defects on the face. (Ann debated due to the lack of homogenous criteria. We describe Dermatol 28(5) 632∼636, 2016) here the case of a 91-year-old female with a 6-month history of a solitary, asymptomatic, well-defined, 3.4-cm-sized, red- -Keywords- dish, hard, protruding mass on the lateral aspect of the right Atypical fibroxanthoma, Histiocytic sarcoma, Malignant fi- upper eyelid.
    [Show full text]
  • Histiocytic Sarcoma Originating in the Lung in a 16-Year-Old Male
    J Clin Exp Hematop Vol. 55, No. 1, June 2015 Case Study Histiocytic Sarcoma Originating in the Lung in a 16-Year-Old Male Sakura Tomita,1) Go Ogura,1) Chie Inomoto,1) Hiroshi Kajiwara,1) Ryota Masuda,2) Masayuki Iwazaki,2) Masaru Kojima,3) and Naoya Nakamura1) We report a 16-year-old male with histiocytic sarcoma (HS) originating in the lung. Partial resection of the lung was performed for a 3-cm mass with a clear boundary detected in the right inferior pulmonary lobe on a health checkup. Histologically, the tumor infiltrated into the surrounding tissue, and was comprised of spindle cells, mainly, and foam cells accompanied by mild nuclear atypia. The tumor cells were immunohistochemically positive for CD68 and CD163, indicating histiocytic lineage and the MIB-1-positive rate was low. Spindle cell morphology of HS is quite rare and only 3 cases of pulmonary HS have previously been reported. 〔J Clin Exp Hematop 55(1) : 45-49, 2015〕 Keywords: histiocytic sarcoma, lung, spindle cells, foamy cells spindle cells, mainly, and foam cells. INTRODUCTION Histiocytic sarcoma (HS) is a malignant hematopoietic CASE REPORT tumor consisting of cells similar to mature histiocytes.1-4 It is extremely rare and the age of onset widely ranges from 6 The patient was a 16-year-old male who exhibited an months to 89 years, with no gender difference; the incidence abnormal shadow detected on a health checkup. He had no is high in adults, showing a large peak at 50-69 years, but also particular past or familial medical history.
    [Show full text]
  • Skin-And-Superficial-Soft-Tissue-Neoplasms-With-Multinuclea 2019 Annals-Of-D.Pdf
    Annals of Diagnostic Pathology 42 (2019) 18–32 Contents lists available at ScienceDirect Annals of Diagnostic Pathology journal homepage: www.elsevier.com/locate/anndiagpath Review Article Skin and superficial soft tissue neoplasms with multinucleated giant cells: T Clinical, histologic, phenotypic, and molecular differentiating features ⁎ Hermineh Aramina,1, Michael Zaleskib,1, Victor G. Prietob, Phyu P. Aungb, a Department of Pathology, Danbury Hospital, Danbury, 24 Hospital Ave., CT, USA b The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, USA ARTICLE INFO ABSTRACT Keywords: Multinucleated giant cells (MGC) are commonly seen in an array of neoplastic and non-neoplastic conditions, to Multinucleated giant cell include: granulomatous dermatitis, fibrohistiocytic lesions such as xanthogranulomas, and soft tissue tumors Squamous cell carcinoma such as giant cell tumors of soft tissue. In addition, multinucleated giant cells are infrequently seen in melanoma, Atypical fibroxanthoma squamous cell carcinoma, and atypical fibroxanthoma. There are many different types of MGCs and theirpre- Melanoma sence, cytologic, and immunohistochemical features within these pathologic entities vary. Thus, correct iden- Reticulohistiocytomas tification of the different types of MGCs can aid the practicing pathologist in making the correct diagnosisofthe Juvenile xanthogranuloma Giant cell tumor of soft tissue overall pathologic disease. The biologic diversity and variation of MGCs is currently best exemplified in cytologic appearance and immunohistochemical profiles. However, much remains unknown about the origination and evolution. In this review, we i) reflect on the various types of MGCs and the current understanding oftheir divergent development, ii) describe the histologic, immunohistochemical, and molecular (if previously reported) differentiating features of common skin and superficial soft tissue neoplasms that may present withmulti- nucleated giant cells.
    [Show full text]
  • Primary Thyroid Sarcoma: a Systematic Review
    ANTICANCER RESEARCH 35: 5185-5192 (2015) Review Primary Thyroid Sarcoma: A Systematic Review ALEXEY SUROV1,2, SEBASTIAN GOTTSCHLING1, ANDREAS WIENKE3, HANS JONAS MEYER1, ROLF PETER SPIELMANN1 and HENNING DRALLE4 Departments of 1Radiology and 4Surgery, and 3Institute of Medical Epidemiology, Biometry, and Informatic, Martin Luther University, Halle-Wittenberg, Germany; 2Department of Diagnostic and Interventionell Radiology, University of Leipzig, Leipzig, Germany Abstract. Different types of malignant tumors can occur images, most sarcomas showed marked non-homogenous within the thyroid. Primary cancer is the most common type enhancement. In 26.8%, infiltration of the adjacent organs of thyroid malignancy. Non-epithelial malignancies can also was seen. The trachea or esophagus was affected more arise within the thyroid. The aim of the present study was to frequently in patients with malignant histiocytoma and analyze clinical and radiological characteristics of reported liposarcoma. Different strategies were used in the treatment primary thyroid sarcomas (PTS), based on a large sample of PTS. Our analysis provides clinical and radiological of cases. The PubMed database was screened for articles characteristics of PTS. The described features should be from between 1990 and 2014. Overall, 86 articles with 142 taken into consideration in the differential diagnosis of patients were identified. Ultrasound evaluation was reported thyroid tumors. for 36 patients. Data regarding computed tomography of the neck were available for 29 cases. Magnetic resonance Different malignant tumors can occur within the thyroid (1- imaging was performed for eight patients. The following 3). Primary cancer is the most common type of thyroid data were retrieved for the identified sarcomas: localization, malignancy (1). There are four sub-types of cancer affecting size, homogeneity, internal texture, and margin the thyroid: follicular, papillary, medullary and anaplastic (1, characteristics.
    [Show full text]